Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CMS

Trump Revokes Biden's Order to Lower Drug Prices for Medicare

President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare enrollees.

Kiplinger

Medicare Price Negotiations To Continue Under the Trump Administration

The Centers for Medicare & Medicaid Services plans to negotiate the prices for 15 new drugs, although it says its seeking "greater transparency" in price talks.

Kiplinger

What to Expect From CMS Energy's Q4 2024 Earnings Report

CMS Energy is slated to release its fourth-quarter results next month, and analysts forecast double-digit drop in its bottom-line figure.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Alzheimer’s may not be from amyloids

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease

Salon

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second presidency.

Investors Business Daily

Is CMS Energy Stock Underperforming the Nasdaq?

CMS Energy has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

The pros and cons of Medicare Advantage plans

Advice to help you choose between Original Medicare and Medicare Advantage plans.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth

These three high-tech micro-cap stocks have made solid business progress in 2024, warranting them to be on investors radars in 2025.

MarketBeat

Over 162,000 Dreamers Cut Off From Affordable Care Act Insurance

A federal court in North Dakota has blocked ACA coverage for DACA recipients in 19 states. Here's what it means.

Kiplinger

Dr. Oz turbocharges Medicare Advantage and everyone monitors their glucose: 10 health care predictions for 2025 from top investors

Although Trump is entering the White House with an electoral mandate, he will not spend any political capital on health care legislation.

Fortune

2025 Open Enrollment: DACA Recipients Can Purchase Affordable Care Act Health Insurance

Over 100,000 people are newly eligible to purchase health insurance from the federal marketplace. Here's what you need to know.

Kiplinger

How backlash to the pandemic helped shape Trump’s health picks - Roll Call

Cabinet health picks include vaccine skeptics, supporters of herd immunity and promoters of hydroxychloroquine to treat COVID-19.

Roll Call

Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump

Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics warn it may hinder patient access and innovation.

Benzinga

Dr. Oz's finanical conflicts of interest

Oz’s holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000

Salon

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Here’s one way to slash Britain’s rate of child poverty: stop dithering and make all fathers pay what’s due

A new report shows a bad situation is getting worse. This really is a case for draconian action from the state, says Guardian columnist Polly Toynbee

The Independent UK

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.

Roll Call

White House rule would expand coverage of anti-obesity drugs - Roll Call

It’s unclear whether incoming President Donald J. Trump will support outgoing President Joe Biden’s plan to insure the weight loss drugs.

Kiplinger

Trump Picks Dr. Oz as Head of Medicare and Medicaid

President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

What Are Wall Street Analysts' Target Price for CMS Energy Stock?

CMS Energy has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Fortune

How Dr. Oz could change Medicare under President Trump

What you might expect from Oz if he runs Medicare, Medicaid, and management of the Affordable Care Act at the 6,000-person CMS.

Top News

Dr. Mehmet Oz Chosen As CMS Administrator By President-Elect Trump

President-elect Trump selects Dr. Mehmet Oz to lead CMS, emphasizing healthcare expertise and commitment to addressing challenges.

Latin Times

Trump Appoints TV Celebrity 'Dr. Oz' To Key US Health Post

The 64-year-old heart surgeon was championed on daytime television by Oprah Winfrey before he entered politics with an unsuccessful bid for a Senate seat in 2022.

The Guardian - US

Who is Mehmet Oz, Trump’s pick to lead Medicare and Medicaid?

Dr Oz, best known for his daytime talkshow, leaned heavily into Trumpism during his failed 2022 run for US Senate

International Business Times

Trump Taps TV's Dr. Oz To Head Massive Medicare, Medicaid Agency

The celebrity physician would oversee spending that accounts for nearly one-quarter of the federal budget to provide health care to about half the country.

1 … 3 4 5 6

People

Chiquita BrooksLaSure

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.